• <listing id="vvvzt"></listing>
    <code id="vvvzt"></code>

    1. <code id="vvvzt"></code><small id="vvvzt"><delect id="vvvzt"></delect></small>
    2. <output id="vvvzt"></output>
      <code id="vvvzt"></code>
            <tt id="vvvzt"><noframes id="vvvzt"></noframes></tt>
              1. <listing id="vvvzt"></listing>

              2. <mark id="vvvzt"><button id="vvvzt"></button></mark>

              3. <tt id="vvvzt"><button id="vvvzt"><td id="vvvzt"></td></button></tt>

                <label id="vvvzt"></label>
                  <label id="vvvzt"></label>
                      <code id="vvvzt"></code>
                    1. <output id="vvvzt"><video id="vvvzt"></video></output>
                    2. <tt id="vvvzt"><button id="vvvzt"><address id="vvvzt"></address></button></tt>

                          1. http://www.tyds.icu
                            Home > Products > Intermediates > Lurasidon Hydrochloride Intermediates > Lurasidone intermediate cas 2746-19-2

                            Lurasidone intermediate cas 2746-19-2

                            Product Description

                            Chemical Name: CIS-5-NORBORNENE-EXO-2,3-DICARBOXYLIC ANHYDRIDE
                            Molecular Formula: C9H8O3
                            Formula Weight: 164.16
                            CAS No.: 2746-19-2

                            2746-19-2

                            Lurasidone is a novel antipsychotic agent approved for the treatment of schizophrenia in a number of countries including the UK, and is also approved in the USA and Canada for the treatment of major depressive episodes associated with bipolar I disorder as either a monotherapy or adjunctive therapy with lithium or valproate. In addition to full antagonist activity at dopamine D2 (Ki(D2) = 1 nM) and serotonin 5-HT2A (Ki(5-HT2A) = 0.5 nM) receptors, the pharmacodynamic profile of lurasidone is notable for its high affinity for serotonin 5-HT7 receptors (Ki(5-HT7) = 0.5 nM) and its partial agonist activity at 5-HT1A receptors (Ki(5-HT1A) = 6.4 nM). Long-term treatment of schizophrenia with lurasidone has been shown to reduce the risk of relapse. Lurasidone appears associated with minimal effects on body weight and low risk for clinically meaningful alterations in glucose, lipids or electrocardiogram parameters.


                            Looking for ideal Lurasidone HCL Intermediate Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Lurasidone INT 3 AKOS B030093 are quality guaranteed. We are China Origin Factory of Ziprasidone EP Impurity A 99% Latuda. If you have any question, please feel free to contact us.

                            Product Categories : Intermediates > Lurasidon Hydrochloride Intermediates

                            Email to this supplier
                            • *Subject:
                            • *Messages:
                              Your message must be between 20-8000 characters
                            Communicate with Supplier?Supplier
                            Mr. Vid Mr. Mr. Vid
                            What can I do for you?
                            Contact Supplier
                            浙江快乐彩走势图快乐12基本走势图
                          2. <listing id="vvvzt"></listing>
                            <code id="vvvzt"></code>

                            1. <code id="vvvzt"></code><small id="vvvzt"><delect id="vvvzt"></delect></small>
                            2. <output id="vvvzt"></output>
                              <code id="vvvzt"></code>
                                    <tt id="vvvzt"><noframes id="vvvzt"></noframes></tt>
                                      1. <listing id="vvvzt"></listing>

                                      2. <mark id="vvvzt"><button id="vvvzt"></button></mark>

                                      3. <tt id="vvvzt"><button id="vvvzt"><td id="vvvzt"></td></button></tt>

                                        <label id="vvvzt"></label>
                                          <label id="vvvzt"></label>
                                              <code id="vvvzt"></code>
                                            1. <output id="vvvzt"><video id="vvvzt"></video></output>
                                            2. <tt id="vvvzt"><button id="vvvzt"><address id="vvvzt"></address></button></tt>

                                                  1. <listing id="vvvzt"></listing>
                                                    <code id="vvvzt"></code>

                                                    1. <code id="vvvzt"></code><small id="vvvzt"><delect id="vvvzt"></delect></small>
                                                    2. <output id="vvvzt"></output>
                                                      <code id="vvvzt"></code>
                                                            <tt id="vvvzt"><noframes id="vvvzt"></noframes></tt>
                                                              1. <listing id="vvvzt"></listing>

                                                              2. <mark id="vvvzt"><button id="vvvzt"></button></mark>

                                                              3. <tt id="vvvzt"><button id="vvvzt"><td id="vvvzt"></td></button></tt>

                                                                <label id="vvvzt"></label>
                                                                  <label id="vvvzt"></label>
                                                                      <code id="vvvzt"></code>
                                                                    1. <output id="vvvzt"><video id="vvvzt"></video></output>
                                                                    2. <tt id="vvvzt"><button id="vvvzt"><address id="vvvzt"></address></button></tt>

                                                                          1. 北京时时游戏官网下载 安徽时时结果走势图 九龙开奖最快报码网址 黑龙江时时规则 福建快三走势一牛 怎么买新时时 香港tm46特马分析资料 赛车pk10前二技巧 梭哈摸牌的时候做记号 辽宁35选7开奖时间 江西时时结果表 永久出特规律公式 河南省快三推荐 百人牛牛技巧公式 成都麻将规则 1999年第10期开奖结果